MUMBAI, India, June 26 -- Intellectual Property India has published a patent application (202621039230 A) filed by Dr. Megha Patel; and Ms. Dilsar Gohil on March 29, 2026, for A Structured Pharmaceutical Counseling System And Method For Enhancing Therapeutic Outcomes In Patients With Diabetes Mellitus.
Inventors include Dr. Megha Patel; and Ms. Dilsar Gohil.
The application for the patent was published on June 19, 2026, under issue no. 25/2026.
Abstract: The present invention relates to a structured pharmaceutical counselling system designed for improving therapeutic outcomes in patients suffering from Diabetes Mellitus. The system comprises a patient assessment module, a personalized counselling module, an adherence monitoring system, a lifestyle modification module, and a follow-up evaluation module. The invention provides a standardized and reproducible counselling protocol incorporating medication education, device training, and behavioural interventions. A structured intervention cycle with quantifiable scoring enhances medication adherence and glycemic control. Experimental data demonstrate a significant reduction in HbA1c levels and complication rates compared to conventional therapy. The invention ensures improved patient compliance, reduced healthcare costs, and better clinical outcomes, thereby offering an efficient and scalable solution for diabetes management in clinical and community pharmacy settings.
Disclaimer: Curated by HT Syndication.
